Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥277.1bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥586.5bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥289.7bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥20.1bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥31.6bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥20.4bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥62.3bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥30.7bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥26.2bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥41.8bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥18.8bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥49.5bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥32.1bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥19.2bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥32.6bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥848.9bnat 2025-09-30Cons.Assets
Total assets¥813.8bnat 2025-03-31Cons.Assets
Total assets¥827.8bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥454.7bnat 2025-09-30Cons.Liabilities
Total liabilities¥438.8bnat 2025-03-31Cons.Liabilities
Net assets / equity¥394.2bnat 2025-09-30Cons.Net assets
Net assets / equity¥375.0bnat 2025-03-31Cons.Net assets
Net assets / equity¥392.3bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥64.7bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥65.1bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥64.4bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.8bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥64.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥68.4bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥32.8bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥93.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥50.7bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥26.5bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥47.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥29.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥7.8bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥48.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥24.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥70.92025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥181.442024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥116.182024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio44.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio44.2%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 65
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥9.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥2.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-04-01 → 2025-09-30¥7.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30¥400m
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30−¥13.4bn
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2025-09-30−¥13.4bn
Engineering Plasticsreportable segmentrevenue2025-04-01 → 2025-09-30¥122.0bn
Engineering Plasticsreportable segmentrevenue external2025-04-01 → 2025-09-30¥121.9bn
Engineering Plasticsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥106m
Engineering Plasticsreportable segmentsegment profit2025-04-01 → 2025-09-30¥11.5bn
Materialsreportable segmentrevenue2025-04-01 → 2025-09-30¥83.1bn
Materialsreportable segmentrevenue external2025-04-01 → 2025-09-30¥77.2bn
Materialsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥5.9bn
Materialsreportable segmentsegment profit2025-04-01 → 2025-09-30¥5.0bn
Medical Healthcarereportable segmentrevenue2025-04-01 → 2025-09-30¥7.6bn
Medical Healthcarereportable segmentrevenue external2025-04-01 → 2025-09-30¥7.6bn
Medical Healthcarereportable segmentsegment profit2025-04-01 → 2025-09-30¥208m
Safetyreportable segmentrevenue2025-04-01 → 2025-09-30¥49.7bn
Safetyreportable segmentrevenue external2025-04-01 → 2025-09-30¥49.7bn
Safetyreportable segmentsegment profit2025-04-01 → 2025-09-30¥2.7bn
Smartreportable segmentrevenue2025-04-01 → 2025-09-30¥18.2bn
Smartreportable segmentrevenue external2025-04-01 → 2025-09-30¥18.2bn
Smartreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥67m
Smartreportable segmentsegment profit2025-04-01 → 2025-09-30¥404m
—segment totalrevenue2025-04-01 → 2025-09-30¥280.7bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥274.6bn
—segment totalrevenue intersegment2025-04-01 → 2025-09-30¥6.1bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥19.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2025-04-01 → 2025-09-30¥290.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-04-01 → 2025-09-30¥277.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-04-01 → 2025-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2025-04-01 → 2025-09-30¥20.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥9.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥2.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥7.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥344m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥13.8bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥13.8bn
Engineering Plasticsreportable segmentrevenue2024-04-01 → 2024-09-30¥124.6bn
Engineering Plasticsreportable segmentrevenue external2024-04-01 → 2024-09-30¥124.5bn
Engineering Plasticsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥96m
Engineering Plasticsreportable segmentsegment profit2024-04-01 → 2024-09-30¥15.2bn
Materialsreportable segmentrevenue2024-04-01 → 2024-09-30¥95.1bn
Materialsreportable segmentrevenue external2024-04-01 → 2024-09-30¥88.5bn
Materialsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥6.6bn
Materialsreportable segmentsegment profit2024-04-01 → 2024-09-30¥14.3bn
Medical Healthcarereportable segmentrevenue2024-04-01 → 2024-09-30¥7.2bn
Medical Healthcarereportable segmentrevenue external2024-04-01 → 2024-09-30¥7.2bn
Medical Healthcarereportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥0
Medical Healthcarereportable segmentsegment profit2024-04-01 → 2024-09-30¥189m
Safetyreportable segmentrevenue2024-04-01 → 2024-09-30¥47.1bn
Safetyreportable segmentrevenue external2024-04-01 → 2024-09-30¥47.1bn
Safetyreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.3bn
Smartreportable segmentrevenue2024-04-01 → 2024-09-30¥19.6bn
Smartreportable segmentrevenue external2024-04-01 → 2024-09-30¥19.6bn
Smartreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥51m
Smartreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
—segment totalrevenue2024-04-01 → 2024-09-30¥293.6bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥286.9bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥6.7bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥31.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥303.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥289.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥13.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥31.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 588
ItemContextValueUnit
Number of shares heldInterimInstant_No2MajorShareholdersMember26541000
Shareholding ratioInterimInstant_No2MajorShareholdersMember0.0999
Number of shares heldInterimInstant_No3MajorShareholdersMember17402000
Shareholding ratioInterimInstant_No3MajorShareholdersMember0.0655
Number of shares heldInterimInstant_No4MajorShareholdersMember9738000
Shareholding ratioInterimInstant_No4MajorShareholdersMember0.0366
Number of shares heldInterimInstant_No5MajorShareholdersMember8390000
Shareholding ratioInterimInstant_No5MajorShareholdersMember0.0316
Number of shares heldInterimInstant_No6MajorShareholdersMember6777000
Shareholding ratioInterimInstant_No6MajorShareholdersMember0.0255
Number of shares heldInterimInstant_No7MajorShareholdersMember6199000
Shareholding ratioInterimInstant_No7MajorShareholdersMember0.0233
Number of shares heldInterimInstant_No8MajorShareholdersMember5957000
Shareholding ratioInterimInstant_No8MajorShareholdersMember0.0224
Number of shares heldInterimInstant_No9MajorShareholdersMember5322000
Shareholding ratioInterimInstant_No9MajorShareholdersMember0.0200
Number of shares heldInterimInstant_No10MajorShareholdersMember4544000
Shareholding ratioInterimInstant_No10MajorShareholdersMember0.0171
Number of shares heldInterimInstant130385000
Shareholding ratioInterimInstant0.4911
Number of shares issued shares voting rightsInterimInstant_SharesWithNoVotingRightsMember-
Number of shares issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember-
Number of shares issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of voting rights issued shares voting rightsInterimInstant_SharesWithRestrictedVotingRightsOtherMember-
Number of shares issued shares voting rightsInterimInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember1446000
Number of shares issued shares voting rightsInterimInstant_OrdinarySharesReciprocalHoldingSharesWithFullVotingRightsTreasurySharesEtcMember487300
Number of voting rights issued shares voting rightsInterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember2647986
Number of shares issued shares voting rightsInterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember264798600
Number of shares issued shares voting rightsInterimInstant_OrdinarySharesSharesLessThanOneUnitMember210782
Number of shares issued shares voting rightsInterimInstant266942682
Number of voting rights issued shares voting rightsInterimInstant2647986
Number of shares held in own name treasury shares etcInterimInstant_Row1Member1446000
Number of shares held in others names treasury shares etcInterimInstant_Row1Member-
Total number of shares held treasury shares etcInterimInstant_Row1Member1446000
Shareholding ratio treasury shares etcInterimInstant_Row1Member0.0054
Number of shares held in own name treasury shares etcInterimInstant_Row2Member480000
Number of shares held in others names treasury shares etcInterimInstant_Row2Member7300
Total number of shares held treasury shares etcInterimInstant_Row2Member487300
Shareholding ratio treasury shares etcInterimInstant_Row2Member0.0018
Number of shares held in own name treasury shares etcInterimInstant1926000
Number of shares held in others names treasury shares etcInterimInstant7300
Total number of shares held treasury shares etcInterimInstant1933300
Shareholding ratio treasury shares etcInterimInstant0.0072
Number of male directors and other officersFilingDateInstant12
Number of female directors and other officersFilingDateInstant3
Ratio of female directors and other officersFilingDateInstant0.20
Cash and depositsPrior1YearInstant65142000000JPY
Cash and depositsInterimInstant64684000000JPY
Notes and accounts receivable tradePrior1YearInstant113935000000JPY
Notes and accounts receivable tradeInterimInstant102839000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass